Cargando…

Resveratrol Butyrate Ester Protects Adenine-Treated Rats against Hypertension and Kidney Disease by Regulating the Gut–Kidney Axis

Despite recent advances in pharma-nutritional management, chronic kidney disease (CKD) remains an increasingly prevalent disorder. Resveratrol, a pleiotropic phytochemical, has been found to reduce the risk for several chronic diseases. Considering the low bioavailability of resveratrol, we recently...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsu, Chien-Ning, Hou, Chih-Yao, Chang, Chi-I, Tain, You-Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772985/ https://www.ncbi.nlm.nih.gov/pubmed/35052587 http://dx.doi.org/10.3390/antiox11010083

Ejemplares similares

Dietary Resveratrol Butyrate Monoester Supplement Improves Hypertension and Kidney Dysfunction in a Young Rat Chronic Kidney Disease Model
por: Tain, You-Lin, et al.
Publicado: (2023)

Resveratrol Butyrate Ester Supplementation Blunts the Development of Offspring Hypertension in a Maternal Di-2-ethylhexyl Phthalate Exposure Rat Model
por: Tain, You-Lin, et al.
Publicado: (2023)

Separation and Identification of Resveratrol Butyrate Ester Complexes and Their Bioactivity in HepG2 Cell Models
por: Shih, Ming-Kuei, et al.
Publicado: (2021)

Sodium Thiosulfate Improves Hypertension in Rats with Adenine-Induced Chronic Kidney Disease
por: Hsu, Chien-Ning, et al.
Publicado: (2022)

Melatonin Prevents Chronic Kidney Disease-Induced Hypertension in Young Rat Treated with Adenine: Implications of Gut Microbiota-Derived Metabolites
por: Hsu, Chien-Ning, et al.
Publicado: (2021)

Anti-Hypertensive Property of an NO Nanoparticle in an Adenine-Induced Chronic Kidney Disease Young Rat Model
por: Tain, You-Lin, et al.
Publicado: (2023)

Maternal Adenine-Induced Chronic Kidney Disease Programs Hypertension in Adult Male Rat Offspring: Implications of Nitric Oxide and Gut Microbiome Derived Metabolites
por: Hsu, Chien-Ning, et al.
Publicado: (2020)

Perinatal Resveratrol Therapy Prevents Hypertension Programmed by Maternal Chronic Kidney Disease in Adult Male Offspring: Implications of the Gut Microbiome and Their Metabolites
por: Hsu, Chien-Ning, et al.
Publicado: (2020)

Preventive Aspects of Early Resveratrol Supplementation in Cardiovascular and Kidney Disease of Developmental Origins
por: Hsu, Chien-Ning, et al.
Publicado: (2021)

Resveratrol Butyrate Esters Inhibit Obesity Caused by Perinatal Exposure to Bisphenol A in Female Offspring Rats
por: Shih, Ming-Kuei, et al.
Publicado: (2021)

Resveratrol Butyrate Esters Inhibit BPA-Induced Liver Damage in Male Offspring Rats by Modulating Antioxidant Capacity and Gut Microbiota
por: Liao, Jin-Xian, et al.
Publicado: (2021)

Role of the Gut Microbiota in Children with Kidney Disease
por: Tain, You-Lin, et al.
Publicado: (2023)

Perinatal Resveratrol Therapy to Dioxin-Exposed Dams Prevents the Programming of Hypertension in Adult Rat Offspring
por: Hsu, Chien-Ning, et al.
Publicado: (2021)

Gasotransmitters for the Therapeutic Prevention of Hypertension and Kidney Disease
por: Hsu, Chien-Ning, et al.
Publicado: (2021)

Synthesis and Characterization of Novel Resveratrol Butyrate Esters That Have the Ability to Prevent Fat Accumulation in a Liver Cell Culture Model
por: Tain, You-Lin, et al.
Publicado: (2020)

Hydrogen Sulfide in Hypertension and Kidney Disease of Developmental Origins
por: Hsu, Chien-Ning, et al.
Publicado: (2018)

Chronic Kidney Disease and Gut Microbiota: What Is Their Connection in Early Life?
por: Hsu, Chien-Ning, et al.
Publicado: (2022)

Perinatal Propionate Supplementation Protects Adult Male Offspring from Maternal Chronic Kidney Disease-Induced Hypertension
por: Tain, You-Lin, et al.
Publicado: (2022)

Regulation of Nitric Oxide Production in the Developmental Programming of Hypertension and Kidney Disease
por: Hsu, Chien-Ning, et al.
Publicado: (2019)

Developmental Programming and Reprogramming of Hypertension and Kidney Disease: Impact of Tryptophan Metabolism
por: Hsu, Chien-Ning, et al.
Publicado: (2020)

Adverse Impact of Environmental Chemicals on Developmental Origins of Kidney Disease and Hypertension
por: Hsu, Chien-Ning, et al.
Publicado: (2021)

Cardiovascular Risks of Hypertension: Lessons from Children with Chronic Kidney Disease
por: Tain, You-Lin, et al.
Publicado: (2022)

Protection by Means of Perinatal Oral Sodium Thiosulfate Administration against Offspring Hypertension in a Rat Model of Maternal Chronic Kidney Disease
por: Tain, You-Lin, et al.
Publicado: (2023)

Perinatal Garlic Oil Supplementation Averts Rat Offspring Hypertension Programmed by Maternal Chronic Kidney Disease
por: Tain, You-Lin, et al.
Publicado: (2022)

Targeting the Renin–Angiotensin–Aldosterone System to Prevent Hypertension and Kidney Disease of Developmental Origins
por: Hsu, Chien-Ning, et al.
Publicado: (2021)

Iodomethylcholine Inhibits Trimethylamine-N-Oxide Production and Averts Maternal Chronic Kidney Disease-Programmed Offspring Hypertension
por: Tain, You-Lin, et al.
Publicado: (2023)

Blood Pressure Abnormalities Associated with Gut Microbiota-Derived Short Chain Fatty Acids in Children with Congenital Anomalies of the Kidney and Urinary Tract
por: Hsu, Chien-Ning, et al.
Publicado: (2019)

AMP-Activated Protein Kinase as a Reprogramming Strategy for Hypertension and Kidney Disease of Developmental Origin
por: Tain, You-Lin, et al.
Publicado: (2018)

Early-Life Programming and Reprogramming of Adult Kidney Disease and Hypertension: The Interplay between Maternal Nutrition and Oxidative Stress
por: Hsu, Chien-Ning, et al.
Publicado: (2020)

A novel model of adenine-induced chronic kidney disease-associated gastrointestinal dysfunction in mice: The gut-kidney axis
por: Hayeeawaema, Fittree, et al.
Publicado: (2023)

Hypertension of Developmental Origins: Consideration of Gut Microbiome in Animal Models
por: Tain, You-Lin, et al.
Publicado: (2022)

Maternal N-Acetylcysteine Therapy Prevents Hypertension in Spontaneously Hypertensive Rat Offspring: Implications of Hydrogen Sulfide-Generating Pathway and Gut Microbiota
por: Hsu, Chien-Ning, et al.
Publicado: (2020)

Reprogramming Effects of Postbiotic Butyrate and Propionate on Maternal High-Fructose Diet-Induced Offspring Hypertension
por: Tain, You-Lin, et al.
Publicado: (2023)

Synthesis of Short-Chain-Fatty-Acid Resveratrol Esters and Their Antioxidant Properties
por: Tain, You-Lin, et al.
Publicado: (2021)

Dietary Supplementation with Cysteine during Pregnancy Rescues Maternal Chronic Kidney Disease-Induced Hypertension in Male Rat Offspring: The Impact of Hydrogen Sulfide and Microbiota-Derived Tryptophan Metabolites
por: Hsu, Chien-Ning, et al.
Publicado: (2022)

The First Thousand Days: Kidney Health and Beyond
por: Hsu, Chien-Ning, et al.
Publicado: (2021)

Developmental Programming of the Metabolic Syndrome: Can We Reprogram with Resveratrol?
por: Tain, You-Lin, et al.
Publicado: (2018)

Hypertension Programmed by Perinatal High-Fat Diet: Effect of Maternal Gut Microbiota-Targeted Therapy
por: Hsu, Chien-Ning, et al.
Publicado: (2019)

The Interplay between Maternal and Post-Weaning High-Fat Diet and Gut Microbiota in the Developmental Programming of Hypertension
por: Hsu, Chien-Ning, et al.
Publicado: (2019)

Maternal Resveratrol Therapy Protects Male Rat Offspring against Programmed Hypertension Induced by TCDD and Dexamethasone Exposures: Is It Relevant to Aryl Hydrocarbon Receptor?
por: Hsu, Chien-Ning, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_il9qm64k748rigj69f5o3plpiv